Mind Science

   

New Therapeutic Intervention and Assessment Tools: GSR, Sexual Dysfunction and the Peptide Assisted Therapy Method––an Applied Therapy and Mathematical Metric of Healing.

Authors: Richard Lawrence Norman

This adjunct to our previous work (Norman and Conte et al. 2016, 2016a) will apply the proposed methodology within a specific clinical paradigm in order to aid the ever increasing population afflicted with sexual dysfunction and more subtle relationship issues. As has been previously supported, GSR is a noninvasive alternative to other measures which is capable of reaching into the deepest unconscious layers of the human mind. We will propose a specific series of tests and treatments which may allow risk-free aid to be disseminated to needful populations and treatment efficacy evaluated in precise mathematical terms supported by known trustworthy psychological measures. We may thereby develop and substantiate from several fronts at once, both a new therapeutic approach specifically aimed at a large target population in present need of care, and also, the methods of mathematical evaluation applied. The Peptide Assisted Therapy (PAT) method utilizes the known fact of oxytocin induced hippocampal mnemic plasticity within a neuropsychoanalytic context, to reshape basic attachment structure dynamics in order to ameliorate active pathology. A detailed protocol is presented relating the previously articulated methodology to the current theoretic construct and its applicability. In this way we will suggest new avenues of approach, analysis, theoretic substantiation and treatment which may directly help those afflicted with a common condition. Qualification and importance: It must be qualified that the proposed treatment is new, safe, non-toxic and remains to be assessed. Although it is unlikely that those patients and couples with deeply entrenched libidinal imbalance will benefit from this therapeutic approach outside of a greater and more extensive therapeutic context, those whose condition is less severe may well receive substantial benefit. With ~30% of all men and ~40% of all women displaying some level of sexually dysfunctional symptomatology, (ASRM fact sheets 2008, 2015) over a complex distribution (Simons and Carey 2001), we may rightly conclude that this safe and inexpensive treatment could help millions, and so, should be closely investigated and quantitatively assessed.

Comments: 16 Pages.

Download: PDF

Submission history

[v1] 2016-07-10 09:29:40

Unique-IP document downloads: 25 times

Vixra.org is a pre-print repository rather than a journal. Articles hosted may not yet have been verified by peer-review and should be treated as preliminary. In particular, anything that appears to include financial or legal advice or proposed medical treatments should be treated with due caution. Vixra.org will not be responsible for any consequences of actions that result from any form of use of any documents on this website.

Add your own feedback and questions here:
You are equally welcome to be positive or negative about any paper but please be polite. If you are being critical you must mention at least one specific error, otherwise your comment will be deleted as unhelpful.

comments powered by Disqus